Page 47 - Comprehensive treatment of patients with glucocorticoid-dependent severe asthma
P. 47
References
1. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med 2000; 162:2341- 51.
2. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008; 372:1107-19.
3. Bel EH, Sousa A, Fleming L, et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax 2011.
4. Bousquet J, Mantzouranis E, Cruz AA, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010; 126:926-38.
5. Robinson DS, Campbell DA, Durham SR, et al. Systematic assessment of difficult-to-treat asthma. Eur Respir J 2003; 22:478-83.
6. Heaney LG, Conway E, Kelly C, et al. Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol. Thorax 2003; 58:561-6.
7. Clerisme-Beaty EM, Bartlett SJ, Teague WG, et al. The Madison Avenue effect: how drug presentation style influences adherence and outcome in patients with asthma. J Allergy Clin Immunol 2011; 127:406-11.
8. Gamble J, Stevenson M, McClean E, Heaney LG. The prevalence of nonadherence in difficult asthma. Am J Respir Crit Care Med 2009; 180:817-22.
9. Greaves CJ, Hyland ME, Halpin DM, et al. Patterns of corticosteroid medication use: non-adherence can be effective in milder asthma. Prim Care Respir J 2005; 14:99-105.
10. Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004; 114:1288-93.
11. Price D, Musgrave SD, Shepstone L, et al. Leukotriene antagonists as first-line or add-on asthma- controller therapy. N Engl J Med 2011; 364:1695-707.
12. Horne R, Weinman J. Self-regulation and self management in asthma: exploring the role of illness perceptions and treatments beliefs in explaining non-adherence to preventer medication. Psychology and Health 2002; 17:17-32.
13. Williams LK, Joseph CL, Peterson EL, et al. Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence. J Allergy Clin Immunol 2007; 120:1153-9.
14. Aburuz S, Heaney LG, Millership J, et al. A cross-sectional study evaluating the relationship between cortisol suppression and asthma control in patients with difficult asthma. Br J Clin Pharmacol 2007; 63:110-5.
15. Gamble J, Stevenson M, Heaney LG. A study of a multi-level intervention to improve non-adherence in difficult to control asthma. Respir Med 2011.
16. Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest 2006; 130:65S-72S.
17. Kolbe J, Vamos M, Fergusson W, et al. Differential influences on asthma self-management knowledge and self-management behavior in acute severe asthma. Chest 1996; 110:1463-8.
18. Chan-Yeung M, Malo JL. Occupational asthma. N Engl J Med 1995; 333:107-12.
19. Kogevinas M, Anto JM, Sunyer J, et al. Occupational asthma in Europe and other industrialised areas: a population-based study. European Community Respiratory Health Survey Study Group. Lancet 1999; 353:1750-4.
20. Boulet LP, Lemiere C, Gautrin D, Cartier A. New insights into occupational asthma. Curr Opin Allergy Clin Immunol 2007;7:96-101.
21. de Groene GJ, Pal TM, Beach J, et al. Workplace interventions for treatment of occupational asthma. Cochrane Database Syst Rev 2011;5:CD006308.
22. Gautrin D, Ghezzo H, Infante-Rivard C, et al. Long-term outcomes in a prospective cohort of apprentices exposed to high-molecular-weight agents. Am J Respir Crit Care Med 2008;177:871-9.
Current treatment of severe asthma
45
2